Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
Lowie Vanfleteren,1–3 Leonardo M Fabbri,1,4 Alberto Papi,4 Stefano Petruzzelli,5 Bartolome Celli6 1COPD Center, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden; 2CIRO, Horn, the Netherlands; 3Department of Respiratory Medicine, Maastric...
Main Authors: | Vanfleteren L, Fabbri LM, Papi A, Petruzzelli S, Celli B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-12-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/triple-therapy-icslabalama-in-copd-time-for-a-reappraisal-peer-reviewed-article-COPD |
Similar Items
-
Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD
by: Strange C, et al.
Published: (2019-06-01) -
Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
by: Vicente Plaza, et al.
Published: (2023-11-01) -
Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS) Study
by: Ye Jin Lee, et al.
Published: (2021-12-01) -
Overactive bladder – 18 years – Part II
by: Jose Carlos Truzzi, et al.
Published: (2016-04-01) -
Treatment after a COPD exacerbation
by: Robbins RA
Published: (2013-07-01)